AZO vs INBX · P/E 21, rev $18.94B vs rev $1.3M
AutoZone Inc (AZO) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. INBX currently screens at market cap $1.28B.
Not investment advice. Open the AZO and INBX stock pages for the full models.
Not investment advice.